Repligen Corp (NASDAQ: RGEN) is -11.85% lower on its value in year-to-date trading and has touched a low of $102.96 and a high of $182.52 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RGEN stock was last observed hovering at around $130.40 in the last trading session, with the day’s loss setting it -3.52%.
Currently trading at $126.88, the stock is -5.24% and -8.41% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.38 million and changing -2.70% at the moment leaves the stock -13.23% off its SMA200. RGEN registered -24.05% loss for a year compared to 6-month loss of -8.46%.
The stock witnessed a 9.28% gain in the last 1 month and extending the period to 3 months gives it a -21.65%, and is -8.05% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.03% over the week and 6.82% over the month.
Repligen Corp (RGEN) has around 1778 employees, a market worth around $7.13B and $650.43M in sales. Fwd P/E is 58.34. Profit margin for the company is -3.53%. Distance from 52-week low is 23.23% and -30.48% from its 52-week high. The company has generated returns on investments over the last 12 months (-0.87%).
The EPS is expected to grow by 6.06% this year
The shares outstanding are 56.18M, and float is at 53.11M with Short Float at 6.10%.
The top institutional shareholder in the company is BLACKROCK INC. with over 7.57 million shares valued at $954.08 million. The investor’s holdings represent 13.5432 of the RGEN Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 5.07 million shares valued at $638.67 million to account for 9.0659 of the shares outstanding. The other top investors are PRICE T ROWE ASSOCIATES INC /MD/ which holds 4.61 million shares representing 8.2464 and valued at over $580.94 million, while STATE STREET CORP holds 3.109 of the shares totaling 1.74 million with a market value of $219.02 million.
Repligen Corp (RGEN) Insider Activity
The most recent transaction is an insider sale by Hunt Anthony, the company’s Director. SEC filings show that Hunt Anthony sold 26,756 shares of the company’s common stock on Mar 17 ’25 at a price of $152.51 per share for a total of $4.08 million. Following the sale, the insider now owns 0.14 million shares.
Repligen Corp disclosed in a document filed with the SEC on Mar 17 ’25 that Pax Margaret (Director) bought a total of 250 shares of the company’s common stock. The trade occurred on Mar 17 ’25 and was made at $150.69 per share for $37672.0. Following the transaction, the insider now directly holds 1043.0 shares of the RGEN stock.
Still, SEC filings show that on Mar 17 ’25, Hunt Anthony (Director) Proposed Sale 26,756 shares at an average price of $150.42 for $4.02 million. The insider now directly holds shares of Repligen Corp (RGEN).
